Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mefro Pharmaceuticals is an Indian pharmaceutical company specializing in the manufacturing, marketing, and distribution of a wide range of healthcare products. The company operates primarily as a PCD Pharma Franchise provider and offers third-party manufacturing services for various dosage forms, including tablets, capsules, injectables, and syrups. Their product portfolio covers diverse therapeutic segments such as anti-infectives, analgesics, and nutritional supplements. Mefro Pharmaceuticals focuses on providing affordable, high-quality generic medicines to the domestic Indian market through an extensive distribution network. The company emphasizes adherence to WHO-GMP standards to ensure product quality and safety.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mefro Pharmaceuticals.